ProfileGDS4718 / 235937_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 75% 80% 45% 83% 87% 71% 74% 80% 86% 84% 84% 84% 68% 66% 75% 75% 83% 60% 71% 39% 84% 85% 82% 81% 85% 71% 83% 69% 80% 75% 73% 57% 77% 81% 74% 75% 72% 76% 78% 27% 80% 71% 66% 69% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.3715675
GSM549102patient 115, normal, homogenized [OPG study]7.7345180
GSM549104patient 119, normal, homogenized [OPG study]5.2595645
GSM549108patient 138, normal, homogenized [OPG study]8.0812683
GSM549119patient 077, normal, homogenized [OPG study]8.7546487
GSM549133patient 032, cancer, homogenized [OPG study]7.0696371
GSM549139patient 042, cancer, homogenized [OPG study]7.245974
GSM549099patient 107, normal, homogenized [OPG study]7.804580
GSM549109patient 139, normal, homogenized [OPG study]8.6288186
GSM549110patient 046, normal, homogenized [OPG study]8.3687384
GSM549114patient 063, normal, homogenized [OPG study]8.4060584
GSM549122patient 082, normal, homogenized [OPG study]8.299884
GSM549134patient 033, cancer, homogenized [OPG study]6.7411968
GSM549136patient 036, cancer, homogenized [OPG study]6.5840166
GSM549140patient 044, cancer, homogenized [OPG study]7.44775
GSM549111patient 047, normal, homogenized [OPG study]7.3298675
GSM549113patient 057, normal, homogenized [OPG study]8.2926283
GSM549132patient 031, cancer, homogenized [OPG study]6.1407860
GSM549137patient 038, cancer, homogenized [OPG study]6.9835871
GSM549142patient 047, cancer, homogenized [OPG study]5.070239
GSM549100patient 110, normal, homogenized [OPG study]8.2482584
GSM549107patient 135, normal, homogenized [OPG study]8.5480185
GSM549115patient 068, normal, homogenized [OPG study]8.1703882
GSM549116patient 072, normal, homogenized [OPG study]8.0138281
GSM549120patient 078, normal, homogenized [OPG study]8.4039885
GSM549131patient 030, cancer, homogenized [OPG study]7.0720871
GSM549118patient 074, normal, homogenized [OPG study]8.2830783
GSM549129patient 027, cancer, homogenized [OPG study]6.822469
GSM549123patient 088, normal, homogenized [OPG study]7.8132580
GSM549124patient 006, cancer, homogenized [OPG study]7.272875
GSM549126patient 015, cancer, homogenized [OPG study]7.1912873
GSM549128patient 025, cancer, homogenized [OPG study]5.9658357
GSM549103patient 117, normal, homogenized [OPG study]7.3984677
GSM549117patient 073, normal, homogenized [OPG study]8.0403481
GSM549138patient 041, cancer, homogenized [OPG study]7.3218474
GSM549141patient 045, cancer, homogenized [OPG study]7.4448675
GSM549130patient 028, cancer, homogenized [OPG study]7.0713772
GSM549101patient 111, normal, homogenized [OPG study]7.3769776
GSM549105patient 128, normal, homogenized [OPG study]7.644378
GSM549106patient 134, normal, homogenized [OPG study]4.3756127
GSM549112patient 048, normal, homogenized [OPG study]7.8946980
GSM549125patient 011, cancer, homogenized [OPG study]6.9371471
GSM549127patient 024, cancer, homogenized [OPG study]6.6012666
GSM549135patient 035, cancer, homogenized [OPG study]6.812169